Modeling defective interfering virus therapy for AIDS: Conditions for DIV survival
DOI10.1016/0025-5564(94)00021-QzbMATH Open0819.92010OpenAlexW1989985532WikidataQ43980149 ScholiaQ43980149MaRDI QIDQ1804865FDOQ1804865
George W. Nelson, Alan S. Perelson
Publication date: 1995
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/0025-5564(94)00021-q
AIDSHIV-1 infectionnumerical simulationT cellstherapyribozymesCD4\(^ +\) cellsdefective interfering virusdeletion mutant virusDIVHIV-1 replicationintercellular interactionlymphoid organs
Medical applications (general) (92C50) Medical epidemiology (92C60) Biochemistry, molecular biology (92C40)
Cites Work
Cited In (4)
- Affinity Hemodialysis for Antiviral Therapy with Specific Application to HIV
- Fighting a virus with a virus: A dynamic model for HIV-1 therapy
- A delayed dynamical model for COVID-19 therapy with defective interfering particles and artificial antibodies
- Quadratic infectious diseases mathematical models: chronic states, sanity levels, and treatment
This page was built for publication: Modeling defective interfering virus therapy for AIDS: Conditions for DIV survival
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1804865)